BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 15507580)

  • 1. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
    JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
    Dial S; Delaney JA; Barkun AN; Suissa S
    JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
    Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
    JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-suppressive drugs and community-acquired pneumonia.
    Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
    Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
    Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
    Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of pneumonia through gastric acid reduction. Partial evaluation of the Integrated Primary Care Information Project (IPCIP)].
    Nitschmann S
    Internist (Berl); 2006 Apr; 47(4):441-2; discussion 442. PubMed ID: 16511690
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term proton pump inhibitor therapy and risk of hip fracture.
    Yang YX; Lewis JD; Epstein S; Metz DC
    JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
    Othman F; Crooks CJ; Card TR
    BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Sataloff RT
    JAMA; 2005 Feb; 293(7):795-6; author reply 796. PubMed ID: 15713765
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
    Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M; Hennessy S; Yang YX
    Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid-suppressive therapy and community-acquired respiratory infections.
    Laheij RJ; Van Ijzendoorn MC; Janssen MJ; Jansen JB
    Aliment Pharmacol Ther; 2003 Oct; 18(8):847-51. PubMed ID: 14535879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid suppression and pneumonia: a clinical indication for rational prescribing.
    Gregor JC
    JAMA; 2004 Oct; 292(16):2012-3. PubMed ID: 15507589
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
    Tamim H; Duranceau A; Chen LQ; Lelorier J
    Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.